Birdwatch Archive

Birdwatch Note Rating

2025-01-01 18:10:59 UTC - HELPFUL

Rated by Participant: 1562290224FD9AA54ADA2AF681490E0F7667EC50B6B34E504033F48E2E4A8869
Participant Details

Original Note:

According to journalists, "SoftBank led an investment of $1.1 billion in Roivant. The investment wasn’t about getting in on Axovant; SoftBank thought intepirdine was unlikely to succeed, the person said. But SoftBank was seeking to invest in [his] wider drug portfolio..." https://www.nytimes.com/2023/06/27/us/politics/vivek-ramaswamy-wealth.html

All Note Details

Original Tweet

All Information

  • noteId - 1872646718988194157
  • participantId -
  • raterParticipantId - 1562290224FD9AA54ADA2AF681490E0F7667EC50B6B34E504033F48E2E4A8869
  • createdAtMillis - 1735755059902
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 1
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 18726467189881941571562290224FD9AA54ADA2AF681490E0F7667EC50B6B34E504033F48E2E4A8869